semaglutide adolescent obesity trial 2022 Frontiers | Case report: Long-term efficacy and safety of in the treatment of syndromic in Prader Willi syndrome Semaglutide in Adolescent Obesity |

This centrally produced GLP-1 reaches specific receptors located in key structures involved in appetite regulation, such as the paraventricular nucleus, the lateral septum, the nucleus accumbens and the lateral parabrachial nucleus.2,3,6 Furthermore, it promotes aversive responses, inhibits neuroinflammation and gastric emptying, and stimulates sympathetic tone and thermogenesis in experimental models.2,4,6 Activation of GLP-1R on neurons in the arcuate nucleus stimulates the production of pro-opiomelanocortin (POMC), which in turn inhibits neurons that produce neuropeptide Y (NPY), thereby generating an appetite-suppressing response.2 GLP-1 production has also been reported in the olfactory bulb, although its significance remains unclear.2,6 GLP-1R has been identified in the sinoatrial node, atrial and ventricular myocytes, and vascular endothelium

Weight Loss and Fluid Shifts : GLP-1 medications typically produce significant weight loss, particularly in the initial months of treatment

When youre dehydrated, your bodys ability to absorb nutrients and medications is impaired, which can worsen Semaglutides side effects

These specialists work with you to treat hormonal causes of weight gain

Body fat percentage is going down

doi: 10.1016/S0022-3476(09)90024-5 129 FowdenALForheadAJ